Poster presented at the American College of Neuropsychopharmacology (ACNP) Annual Meeting, Hollywood, FL, December 2006.
Lawrence S. Brown Jr., MD, MPH (Addiction Research and Treatment Corporation, NY Node), Steven Allan Kritz, MD (Addiction Research and Treatment Corporation, NY Node), John Rotrosen, MD (New York University, NY Node), R. Jeffrey Goldsmith, MD (Cincinnati VA/CinARC, OV Node), Edmund J. Bini, MD, MPH (VA New York Harbor Healthcare System, NY Node), James A. Robinson, MEd (Nathan Kline Institute for Psychiatric Research, NY/LI Node), Donald Alderson, MS (New York State Psychiatric Institute, NY Node), CTN Infections Study Team (CTN-0012).
This poster describes the design, objectives, procedures, and outcomes of one facet of protocol CTN-0012 ("Characteristics of Screening, Evaluation, and Treatment of HIV/AIDS, Hepatitis C Viral Infections, and Sexually Transmitted Infections in Substance Abuse Treatment Programs"). The protocol examined the associations between HIV/AIDS, hepatitis C (HCV), and sexually transmitted infection (STI)-related services provided by substance abuse treatment programs in the National Institute on Drug Abuse Clinical Trials Network (NIDA CTN), and the states within which they are located.
This poster focuses on exploring the data from CTN-0012 as it pertains specifically to clarity of state guidance on infection-related health services in substance abuse treatment programs. Data for this report was derived from three surveys: one for state health and substance abuse department administrators, and one each for substance abuse treatment program clinicians and administrators. The surveys included questions dealing with eight infection-related services: provider education, patient education, risk assessment, counseling, medical history and physical exam, biological testing, treatment and monitoring. Surveys were obtained from 1723 clinicians (78%) within the NIDA CTN as well as 269 of 319 administrators (84%). With few exceptions, clinician assessment of clarity of state policies, regulations and guidelines for the eight targeted services was generally about 50% or less for all three infection groups. Six of eight services were provided by a similar percentage of programs, regardless of state mandates. Two services (treatment and monitoring) were provided by a substantially higher percentage of sites where there were state policies, regulations or guidelines. This information suggests that state policies, regulations or guidelines are often not clearly understood by clinicians, and even where they exist, they are not sufficient to assure "best practices" in treating these epidemic infections. (Poster, PowerPoint slides, English, 2006)
Keywords: Community health services | Health services research | Hepatitis C | HIV/AIDS | Sexually transmitted diseases | American College of Neuropsychopharmacology (ACNP) annual meeting, 2006
Document No: 196
Submitted by Steven Kritz, M.D., New York Node (6/11/2007).